Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients

Somers, Emily C.; Zhao, Wenpu; Lewis, Emily E.; Wang, Lu; Wing, Jeffrey J.; Sundaram, Baskaran; Kazerooni, Ella A.; McCune, W. Joseph; Kaplan, Mariana J.

Home
→
Research Collections
→
Internal Medicine, Department of
→
View Item

Somers, Emily C.; Zhao, Wenpu; Lewis, Emily E.; Wang, Lu; Wing, Jeffrey J.; Sundaram, Baskaran; Kazerooni, Ella A.; McCune, W. Joseph; Kaplan, Mariana J.

2012

Citation: Somers EC, Zhao W, Lewis E, Wang L, Wing J, Sundaram B, Kazerooni E, McCune WJ, Kaplan MJ. Type I interferons are associated with vascular risk and preclinical atherosclerosis in a cohort of lupus patients without overt cardiovascular disease. PLoS One 2012; 7(5): e37000 [Epub ahead of print]. PMID: 22606325; PMCID: PMC3351452 <http://hdl.handle.net/2027.42/94405>

Other Identifiers: PMCID: PMC3351452

PMID: 22606325

Handle: http://hdl.handle.net/2027.42/94405

Show full item record